Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Psychological changes in Parkinson disease].

W Danielczyk

    Wiener Medizinische Wochenschrift (1946)
    |August 31, 1986
    PubMed
    Summary

    Psychiatric disturbances in Parkinson's disease (PD) patients, primarily toxic psychoses from medication, impact treatment. Depression and dementia are also present but not exclusive to PD.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oxidative stress related markers in the "VITA" and the centenarian projects.

    Neurobiology of aging·2005
    Same author

    Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome.

    Neuroscience letters·2000
    Same author

    Platelet monoamine oxidase B activity in dementia. A 4-year follow-up.

    Dementia and geriatric cognitive disorders·1998
    Same author

    Blood transferrin and ferritin in Alzheimer's disease.

    Life sciences·1997
    Same author

    Calculation abilities in dementia of Alzheimer's type and in vascular dementia.

    Archives of gerontology and geriatrics·1996
    Same author

    Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.

    Journal of neural transmission (Vienna, Austria : 1996)·1996

    Area of Science:

    • Neurology
    • Psychiatry

    Context:

    • Parkinson's disease (PD) is a neurodegenerative disorder.
    • Psychiatric complications are common in PD patients.
    • Antiparkinsonian therapy can trigger toxic psychoses.

    Purpose:

    • To analyze the prevalence and characteristics of psychiatric disturbances in Parkinson's disease.
    • To differentiate PD-related psychiatric issues from other conditions.
    • To understand the relationship between disease progression, medication, and psychiatric symptoms.

    Summary:

    • The most frequent psychiatric issues in Parkinson's disease are reversible toxic psychoses, often linked to antiparkinsonian therapy.
    • Depression and dementia syndromes also occur, influenced by age, disease duration, and medication.
    • Pharmacotoxic psychoses affect a majority in later PD stages, limiting treatment options.
    • Depression is not inherent to PD, as it's common in other chronic diseases.
    • Dementia's severity in PD is often less than in other cerebral diseases like Semantic Dementia (SDAT) or Multi-Infarct Dementia (MID), though co-occurrence is possible with aging.

    Impact:

    • Highlights the significant impact of psychiatric complications on Parkinson's disease management.
    • Informs clinical practice regarding medication side effects and patient monitoring.
    • Contributes to a better understanding of the complex interplay between neurodegeneration and mental health in PD.

    Related Experiment Videos